Cigarette Smoking, BPDE-DNA Adducts, and Aberrant Promoter Methylations of Tumor Suppressor Genes (TSGs) in NSCLC from Chinese Population

Cancer Investigation

Volumn 34, Issue 4, 2016, Pages 173-180

  Jin, Yongtang ^a   Xu, Peiwei ^a   Liu, Xinneng ^a   Zhang, Chunye ^a   Tan, Cong ^a   Chen, Chunmei ^a   Sun, Xiaoyu ^a   Xu, Yingchun ^b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Cigarette smoking; DNA adduct; Gene methylation; Lung cancer

Indexed keywords

BENZO(A)PYRENE 7,8 DIOL 9,10 EPOXIDE; CARCINOGEN; UNCLASSIFIED DRUG; BENZO(A)PYRENE-7,8-DIHYDRODIOL-9,10-EPOXIDE-DNA; BENZO[A]PYRENE 7,8 DIHYDRODIOL 9,10 OXIDE; DNA ADDUCT;

ADULT; AGED; ARTICLE; CANCER PATIENT; CHINESE; COMPARATIVE STUDY; DISEASE ASSOCIATION; DNA ADDUCT; DNA EXTRACTION; DNA METHYLATION; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROMOTER REGION; SMOKING; SQUAMOUS CELL LUNG CARCINOMA; TUMOR SUPPRESSOR GENE; ASIAN CONTINENTAL ANCESTRY GROUP; GENETICS; LUNG TUMOR; METABOLISM;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, NON-SMALL-CELL LUNG; DNA ADDUCTS; DNA METHYLATION; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; SMOKING;

EID: 84962045070     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2016.1156689     Document Type: Article

References (31)

1. International Agency for Research on Cancer. Tobacco smoke and involuntary smoking. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 83, pp 33-1187, IARC, Lyon, France.
2. Vaissière T, Hung RJ, Zaridze D, Moukeria A, Cuenin C, Fasolo V, et al. Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res 2009; 69: 243-252.
3. Reid ME, Santella R, Ambrosone CB. Molecular epidemiology to better predict lung cancer risk. Clin Lung Cancer 2008; 9: 149-153.
4. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. NSCLC: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 2008; 83: 584-594.
5. Peluso M, Munnia A, Piro S, Armillis A, Ceppi M, Matullo G., et al. Smoking, DNA adducts and number of risk DNA repair alleles in lung cancer cases, in subjects with benign lung diseases and in controls. J Nucleic Acids 2010; 2010: 386798.
6. Zhong Y, Carmella SG, Upadhyaya P, Hochalter JB, Rauch D, Oliver A, et al. Immediate consequences of cigarette smoking: rapid formation of polycyclic aromatic hydrocarbon diol epoxides. Chem Res Toxicol 2011; 24: 246-252.
7. Alexandrov K, Rojas M, Satarug S. The critical DNA damage by benzo(a)pyrene in lung tissues of smokers and approaches to preventing its formation. Toxicol Lett 2010; 198: 63-68.
8. Shinmura K, Iwaizumi M, Igarashi H, Nagura K, Yamada H, Suzuki M., et al. Induction of centrosome amplification and chromosome instability in p53-deficient lung cancer cells exposed to benzo[a]pyrene diol epoxide (B[a]PDE). J Pathol 2008; 216: 365-374.
9. Esteller M. Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br J Cancer 2006; 94: 179-183.
10. Vineis P, Perera F. Molecular epidemiology and biomarkers in etiologic cancer research: the new in light of the old. Cancer Epidemiol Biomarkers Prev 2007; 16: 1954-1965.
11. Suzuki M, Yoshino I. Aberrant methylation in NSCLC. Surg Today 2010; 40: 602-607.
12. Jin Y, Xu H, Zhang C, Kong Y, Hou Y, Xu Y, et al. Combined effects of cigarette smoking, gene polymorphisms and methylations of tumor suppressor genes on non small cell lung cancer: a hospital-based case-control study in China. BMC Cancer 2010; 10: 422.
13. Wu JY, Wang J, Lai JC, Cheng YW, Yeh KT, Wu TC, et al. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in NSCLC with different histology, gender, and smoking status. Ann Surg Oncol 2008; 15: 3272-3277.
14. Kim Y, Jin D, Lee BB, Cho EY, Han J, Shim YM, et al. RARβ2 hypermethylation is associated with poor recurrence-free survival in never-smokers with adenocarcinoma of the lung. Clin Epigenetics 2015; 7: 32.
15. Liu Y, Gao W, Siegfried JM, Weissfeld JL, Luketich JD, Keohavong P. Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers. BMC Cancer 2007; 7: 74.
16. Sanyal MK, Mercan D, Belanger K, Santella RM. DNA adducts in human placenta exposed to ambient environment and passive cigarette smoke during pregnancy. Birth Defects Res A Clin Mol Teratol 2007; 79: 289-294.
17. McCarty KM, Santella RM, Steck SE, Cleveland RJ, Ahn J, Ambrosone CB, et al., PAH-DNA adducts, cigarette smoking, GST polymorphisms, and breast cancer risk. Environ Health Perspect 2009; 117: 552-558.
18. Liu C, Li P, Gao D, Zhou P, Shao Y, Zhang Q, et al. Abnormal promoter methylation of multiple tumor suppressor genes in human bronchial epithelial malignant cells. Biomed Rep 2014; 2: 525-528.
19. Gyorffy E, Anna L, Gyori Z, Segesdi J, Minárovits J, Soltész I, et al. DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay. Carcinogenesis 2004; 25: 1201-1209.
20. Anna L, Holmila R, Kovács K, Gyorffy E, Gyori Z, Segesdi J, et al. Relationship between TP53 tumour suppressor gene mutations and smoking-related bulky DNA adducts in a lung cancer study population from Hungary. Mutagenesis 2009; 24: 475-480.
21. International Agency for Research on Cancer. Tobacco smoke and involuntary smoke. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans 2004; 83: 1-1438.
22. Schwerdtle T, Ebert F, Thuy C, Richter C, Mullenders LH, Hartwig A. Genotoxicity of soluble and particulate cadmium compounds: impact on oxidative DNA damage and nucleotide excision repair. Chem Res Toxicol 2010; 23: 432-442.
23. Alexandrov K, Rojas M, Rolando C. DNA damage by benzo(a)pyrene in human cells is increased by cigarette smoke and decreased by a filter containing rosemary extract, which lowers free radicals. Cancer Res 2006; 66: 11938-11945.
24. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3: 415-428.
25. Liu Y, Lan Q, Siegfried JM, Luketich JD, Keohavong P. Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients. Neoplasia 2006; 8: 46-51.
26. Hawes SE, Stern JE, Feng Q, Wiens LW, Rasey JS, Lu H, et al. DNA hypermethylation of tumors from non-small cell lung cancer (NSCLC) patients is associated with gender and histologic type. Lung Cancer 2010; 69: 172-179.
27. Vaissière T, Hung RJ, Zaridze D, Moukeria A, Cuenin C, Fasolo V, et al. Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res 2009; 69: 243-252.
28. Mezzanotte JJ, Hill V, Schmidt ML, Shinawi T, Tommasi S, Krex D, et al. RASSF6 exhibits promoter hypermethylation in metastatic melanoma and inhibits invasion in melanoma cells. Epigenetics 2014; 9: 1496-1503.
29. Toyooka S, Tokumo M, Shigematsu H, Matsuo K, Asano H, Tomii K, et al. Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers. Cancer Res 2006; 66: 1371-1375.
30. Pavanello S, Bollati V, Pesatori AC, Kapka L, Bolognesi C, Bertazzi PA, et al. Global and gene-specific promoter methylation changes are related to anti-B(a)PDE-DNA adduct levels and influence micronuclei levels in polycyclic aromatic hydrocarbon-exposed individuals. Int J Cancer 2009; 125: 1692-1697.
31. Shigematsu H, Lin L, Takahashi T, Nomura M, Suzuki M, Wistuba II, et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 2005; 97: 339-346.